{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:57:39Z","timestamp":1790017059353,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jad.2024.06.032","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:53:20Z","timestamp":1718625200000},"page":"434-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The blood-brain barrier in bipolar disorders: A systematic review"],"prefix":"10.1016","volume":"361","author":[{"given":"Clara","family":"Wakonigg Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"McElhatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.A.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood\u2013brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.jad.2024.06.032_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum S100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.06.032_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbi.2021.09.003","article-title":"Low peripheral mitochondrial DNA copy number during manic episodes of bipolar disorders is associated with disease severity and inflammation","volume":"98","author":"Angrand","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0035","first-page":"70","article-title":"Serum S100B levels in patients with depression","volume":"61","author":"Arora","year":"2019","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.032_bb0050","article-title":"The challenge of assessing mild neuroinflammation in severe mental disorders","volume":"11","author":"Bechter","year":"2020","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","article-title":"Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood\u2013CSF barrier dysfunction","volume":"44","author":"Bechter","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.jad.2024.06.032_bb0060","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.4088\/JCP.v69n1203","article-title":"Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features","volume":"69","author":"Berghofer","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/JAD-122155","article-title":"Amyloid-\u03b2 interacts with blood-brain barrier function in dementia: a systematic review","volume":"35","author":"Burgmans","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0070","first-page":"375-379.*","article-title":"Expression of matrix metalloproteinases in patients with bipolar disorder. Brazilian journal of","volume":"35","author":"Chiarani","year":"2013","journal-title":"Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21037\/tlcr.2016.07.08","article-title":"S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer","volume":"5","author":"Choi","year":"2016","journal-title":"Translational lung cancer research"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0085","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.jad.2024.06.032_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073520","article-title":"A combined marker of inflammation in individuals with mania","volume":"8","author":"Dickerson","year":"2013","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.jad.2024.06.032_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0165-5728(02)00114-5","article-title":"The adhesion molecule ICAM-1 and its regulation in relation with the blood\u2013brain barrier","volume":"128","author":"Di\u00e9trich","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jad.2024.06.032_bb0100","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1073\/pnas.1914655117","article-title":"Molecular adaptations of the blood\u2013brain barrier promote stress resilience vs","volume":"117","author":"Dudek","year":"2020","journal-title":"Depression. Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.jad.2024.06.032_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainres.2014.08.011","article-title":"Adverse effects of antipsychotics on micro-vascular endothelial cells of the human blood\u2013brain barrier","volume":"1583","author":"Elmorsy","year":"2014","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.seizure.2011.01.010","article-title":"Overexpression of \u03bc-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics","volume":"20","author":"Feng","year":"2011","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.jad.2024.06.032_bb0120","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.euroneuro.2016.07.009","article-title":"Increased mRNA expression of peripheral glial cell markers in bipolar disorder: the effect of long-term lithium treatment","volume":"26","author":"Ferensztajn-Rochowiak","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2024.06.032_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.185","article-title":"Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders","volume":"5","author":"Frye","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2020.100102","article-title":"Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case-control studies","volume":"6","author":"Futtrup","year":"2020","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0135","article-title":"Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Translational","volume":"10","author":"Greene","year":"2020","journal-title":"Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-019-0123-z","article-title":"Claudin-5: gatekeeper of neurological function","volume":"16","author":"Greene","year":"2019","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.jad.2024.06.032_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","article-title":"Status epilepticus, blood\u2013brain barrier disruption, inflammation, and epileptogenesis","volume":"49","author":"Gorter","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jad.2024.06.032_bb0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbi.2020.05.001","article-title":"Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies","volume":"88","author":"Gur","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2024.06.032_bb0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","article-title":"Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3\u03b2 signaling in bipolar patients","volume":"156","author":"Haenisch","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0170","doi-asserted-by":"crossref","first-page":"1-13.*","DOI":"10.1038\/s41398-020-0843-5","article-title":"Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study","volume":"10","author":"Hidese","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb0175","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.celrep.2017.10.026","article-title":"Evolutionarily conserved roles for blood-brain barrier xenobiotic transporters in endogenous steroid partitioning and behavior","volume":"21","author":"Hindle","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jad.2024.06.032_bb0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbi.2023.01.015","article-title":"Serum claudin-5 levels among patients with unipolar and bipolar depression in relation to the pro-inflammatory cytokine tumor necrosis factor-alpha levels","volume":"109","author":"Hochman","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.jad.2024.06.032_bb0185","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"10159","key":"10.1016\/j.jad.2024.06.032_bb0190","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00207459109082042","article-title":"Differential appearance of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients","volume":"60","author":"Jankovi\u0107","year":"1991","journal-title":"Int. J. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb3000","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/mp.2015.107","article-title":"Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging","volume":"21","author":"Jenkins","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-11-12","article-title":"Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke","volume":"11","author":"Jin","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jad.2024.06.032_bb2005","author":"Joanna Briggs Institute"},{"key":"10.1016\/j.jad.2024.06.032_bb0215","article-title":"Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression","volume":"26","author":"Kamintsky","year":"2020","journal-title":"NeuroImage: Clinical"},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0220","first-page":"75","article-title":"Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder","volume":"30","author":"Karabulut","year":"2019","journal-title":"Turk Psikiyatri Dergisi"},{"key":"10.1016\/j.jad.2024.06.032_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2020.01.117","article-title":"Serum zonulin and claudin-5 levels in patients with bipolar disorder","volume":"266","author":"K\u0131l\u0131\u00e7","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"23","key":"10.1016\/j.jad.2024.06.032_bb0230","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1182\/blood-2008-10-186650","article-title":"Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis","volume":"113","author":"Kisucka","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jad.2024.06.032_bb0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jad.2021.10.074","article-title":"Alzheimer\u2019s disease related biomarkers in bipolar disorder \u2013 a longitudinal one-year case-control study","volume":"297","author":"Knorr","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0240","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s40279-013-0119-9","article-title":"S100B as a marker for brain damage and blood\u2013brain barrier disruption following exercise","volume":"44","author":"Koh","year":"2014","journal-title":"Sports Med."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0245","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pnpbp.2009.02.012","article-title":"Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?","volume":"33","author":"Kucukali","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5021\/ad.2014.26.4.536","article-title":"Clinical significance of serum vascular endothelial-cadherin levels in inflammatory skin diseases","volume":"26","author":"Kuriyama","year":"2014","journal-title":"Ann. Dermatol."},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/bjaceaccp\/mkr018","article-title":"Blood\u2013brain barrier","volume":"11","author":"Lawther","year":"2011","journal-title":"Continuing Education in Anaesthesia Critical Care & Pain"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2011.12.049","article-title":"Can bipolar disorder be viewed as a multi-system inflammatory disease?","volume":"141","author":"Leboyer","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.032_bb0265","article-title":"Matrix metalloproteinase-9 as an important contributor to the pathophysiology of depression","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jad.2024.06.032_bb0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.brainres.2010.02.054","article-title":"Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions","volume":"1326","author":"Lischper","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0924-977X(02)00029-9","article-title":"Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study","volume":"12","author":"Machado-Vieira","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb4005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.12.008","article-title":"Peripheral markers of blood\u2013brain barrier damage","volume":"342","author":"Marchi","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056805","article-title":"Consequences of repeated blood-brain barrier disruption in football players","volume":"8","author":"Marchi","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb0285","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1515\/CCLM.2010.131","article-title":"Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: united we stand, divided we fall","volume":"48","author":"Mattsson","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jad.2024.06.032_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105926","article-title":"Blood brain barrier and inflammation in depression","volume":"175","author":"Medina-Rodriguez","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0295","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group*","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2024.06.032_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1132077","article-title":"Imaging blood-brain barrier dysfunction: a state-of-the-art review from a clinical perspective","volume":"15","author":"Moyaert","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2478\/prilozi-2018-0008","article-title":"Evaluation of the role of ABCB1gene polymorphic variants on psychiatric disorders predisposition in Macedonian population","volume":"38","author":"Naumovska","year":"2017","journal-title":"PRILOZI"},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb4000","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/mp.2010.7","article-title":"Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility","volume":"16","author":"O\u2019Dushlaine","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0315","article-title":"Composite immune marker scores associated with severe mental disorders and illness course","volume":"24","author":"Ormerod","year":"2022","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.128","article-title":"Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala","volume":"5","author":"Pantazopoulos","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archgenpsychiatry.2009.196","article-title":"Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia","volume":"67","author":"Pantazopoulos","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"sup2","key":"10.1016\/j.jad.2024.06.032_bb0330","doi-asserted-by":"crossref","first-page":"S41-S51.*","DOI":"10.1080\/15622975.2016.1259498","article-title":"sVCAM-1, sICAM-1, TNF-\u03b1 and IL-6 levels in bipolar disorder type I: acute, longitudinal and therapeutic implications","volume":"19","author":"Pantovi\u0107-Stefanovi\u0107","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/708306","article-title":"Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?","volume":"2015","author":"Patel","year":"2015","journal-title":"Neural Plast."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0340","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2174\/1570159X14666160616120157","article-title":"Diagnosis and treatment of Cyclothymia: the \u201cprimacy\u201d of temperament","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0345","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","article-title":"Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke","volume":"1862","author":"Pinheiro","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood\u2013brain barrier in psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0355","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190062","article-title":"The blood\u2013brain barrier in health and disease: important unanswered questions","volume":"217","author":"Profaci","year":"2020","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0370","doi-asserted-by":"crossref","first-page":"155-163.*","DOI":"10.1111\/bdi.12380","article-title":"Extracellular matrix proteins matrix metallopeptidase 9 (MMP 9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder","volume":"18","author":"Reininghaus","year":"2016","journal-title":"Bipolar Disord."},{"issue":"9","key":"10.1016\/j.jad.2024.06.032_bb0375","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood\u2013brain barrier: versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0380","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1123\/ijsnem.2016-0009","article-title":"Effect of exercise intensity on neurotrophic factors and blood\u2013brain barrier permeability induced by oxidative\u2013nitrosative stress in male college students","volume":"27","author":"Roh","year":"2017","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"issue":"9","key":"10.1016\/j.jad.2024.06.032_bb0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/2045125318769235","article-title":"Epidemiology and risk factors for bipolar disorder","volume":"8","author":"Rowland","year":"2018","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0390","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jad.2012.07.019","article-title":"Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression","volume":"146","author":"Rybakowski","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0395","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hup.1182","article-title":"Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients","volume":"26","author":"Rybakowski","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12017-009-8072-3","article-title":"Matrix Metalloproteinase-9 gene and Bipolar mood disorder","volume":"11","author":"Rybakowski","year":"2009","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jad.2024.06.032_bb0405","doi-asserted-by":"crossref","first-page":"691","DOI":"10.25259\/JNRP-2022-6-34","article-title":"Matrixmetalloproteinase-9 gene polymorphism (rs 17576) increases the risk of depressive symptoms in bipolar disorder","volume":"13","author":"Saravanan","year":"2022","journal-title":"Journal of Neurosciences in Rural Practice"},{"key":"10.1016\/j.jad.2024.06.032_bb0410","doi-asserted-by":"crossref","unstructured":"Sanchez-Cano, F., Hern\u00e1ndez-Kelly, L. C., & Ortega, A. (2021). The Blood\u2013Brain barrier: much more than a selective access to the brain. Neurotox. Res., 39(6), 2154\u20132174. doi:https:\/\/doi.org\/10.1007\/s12640-021-00431-0.","DOI":"10.1007\/s12640-021-00431-0"},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000446919","article-title":"Soluble intracellular adhesion molecule-1 in patients with unipolar or bipolar affective disorders: results from a pilot trial","volume":"74","author":"Schaefer","year":"2016","journal-title":"Neuropsychobiology"},{"issue":"13","key":"10.1016\/j.jad.2024.06.032_bb0420","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00001756-200209160-00021","article-title":"S100B is increased in mood disorders and may be reduced by antidepressive treatment","volume":"13","author":"Schroeter","year":"2002","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.jad.2024.06.032_bb0425","first-page":"1-14.*","article-title":"The difference in serum proteomes in schizophrenia and bipolar disorder","volume":"20","author":"Smirnova","year":"2019","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jad.2024.06.032_bb0430","doi-asserted-by":"crossref","first-page":"1-9.*","DOI":"10.1016\/j.jad.2014.01.009","article-title":"Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts","volume":"160","author":"S\u00f6dersten","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2024.06.032_bb0435","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jad.2024.06.032_bb0440","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.psyneuen.2009.07.012","article-title":"S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research","volume":"35","author":"Steiner","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"10\u221211","key":"10.1016\/j.jad.2024.06.032_bb0445","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.clinbiochem.2014.01.028","article-title":"Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives","volume":"47","author":"Strathmann","year":"2014","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0450","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1251384","article-title":"Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases","volume":"4","author":"Sturgeon","year":"2016","journal-title":"Tissue barriers"},{"issue":"5","key":"10.1016\/j.jad.2024.06.032_bb0455","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11011-021-00694-8","article-title":"Methods used for the measurement of blood-brain barrier integrity","volume":"36","author":"Sun","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"6","key":"10.1016\/j.jad.2024.06.032_bb0460","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2003.10.015","article-title":"Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder","volume":"55","author":"Thomas","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.comppsych.2016.12.008","article-title":"Decreased S100B serum levels after treatment in bipolar patients in a manic phase","volume":"74","author":"Tsai","year":"2017","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.032_bb0475","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jad.2014.03.052","article-title":"Are ICAM, VCAM and E-selectin levels different in first manic episode and subsequent remission?","volume":"163","author":"Turan","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb2000","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11033-007-9206-z","article-title":"Association of MDR1 C3435T polymorphism with bipolar disorder in patients treated with valproic acid","volume":"36","author":"Turgut","year":"2009","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.jad.2024.06.032_bb0485","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/10409230290771546","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)","volume":"37","author":"Van den Steen","year":"2002","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jad.2024.06.032_bb0500","unstructured":"Wells, G. A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (n.d.). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Retrieved June 2, 2021, from http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"4","key":"10.1016\/j.jad.2024.06.032_bb0515","doi-asserted-by":"crossref","first-page":"382","DOI":"10.30773\/pi.2022.0234","article-title":"Evaluation of serum zonulin and occludin levels in bipolar disorder","volume":"20","author":"Zengil","year":"2023","journal-title":"Psychiatry Investig."},{"issue":"3","key":"10.1016\/j.jad.2024.06.032_bb0520","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.psychres.2014.03.045","article-title":"Blood\u2013cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","volume":"217","author":"Zetterberg","year":"2014","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.jad.2024.06.032_bb0525","article-title":"Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 polymorphisms with schizophrenia in Chinese Han population","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2024.06.032_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2022.100441","article-title":"Blood-brain barrier dysfunction in bipolar disorder: molecular mechanisms and clinical implications","volume":"21","author":"Zhao","year":"2022","journal-title":"Brain, Behavior, & Immunity - Health"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724009649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724009649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T20:12:11Z","timestamp":1726258331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724009649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":93,"alternative-id":["S0165032724009649"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.06.032","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.08.22281826","asserted-by":"object"}]},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The blood-brain barrier in bipolar disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}